BioMarin Pharmaceutical | BMRN - EPS Earnings Per Share


BioMarin Pharmaceutical reported $1.2 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 1.49 0.12 Nov/03
FY2026Q2 Jun/2026 1.20 0.95 1.44 Aug/06
FY2026Q1 Mar/2026 0.76 0.74 1.13 May/04
FY2025Q4 Dec/2025 0.46 0.77 0.92 Feb/23
FY2025Q3 Sep/2025 0.12 0.86 0.91 Oct/27




Eps Change Date
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
Bayer EUR 0.95 1.76 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
Incyte USD 3.09 1.28 Jun/2026
Insmed USD -0.06 0.7 Jun/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Moderna USD -1.97 1.43 Jun/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
PTC Therapeutics USD 0.92 0.95 Jun/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 2.17 2.84 Mar/2026
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
United Therapeutics USD 7.27 1.45 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026